Sugi Predict

Sugi Predict / Compounds / SCHEMBL503441

SCHEMBL503441

SCHEMBL503441

CC12CCC(C(C(=O)O)C1=O)C2(C)C

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 2/20 0.40
▸ ALDH1A1 P00352 4/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ CNR2 P34972 2/20 0.38
▸ DPP4 P27487 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ USP2 O75604 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ HSD11B1 P28845 2/20 0.31
▸ APLNR P35414 1/20 0.30
▸ SLC1A2 P43004 1/20 0.30
▸ SLC1A1 P43005 1/20 0.30
▸ F10 P00742 1/20 0.30
▸ PTPN2 P17706 1/20 0.30
▸ CDC25B P30305 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4372039 1.00 PTPN1 (0.40) PTPN1ALDH1A1SMN1; SMN2HSD17B10CNR2
SCHEMBL17255910 1.00 PTPN1 (0.40) PTPN1ALDH1A1SMN1; SMN2HSD17B10CNR2
SCHEMBL4565223 1.00 PTPN1 (0.40) PTPN1ALDH1A1SMN1; SMN2HSD17B10CNR2
SCHEMBL15151473 1.00 PTPN1 (0.40) PTPN1ALDH1A1SMN1; SMN2HSD17B10CNR2
SCHEMBL4364550 1.00 PTPN1 (0.40) PTPN1ALDH1A1SMN1; SMN2HSD17B10CNR2
SCHEMBL15151497 1.00 PTPN1 (0.40) PTPN1ALDH1A1SMN1; SMN2HSD17B10CNR2
SCHEMBL1313319 0.98 PTPN1 (0.39) PTPN1ALDH1A1SMN1; SMN2HSD17B10CNR2
SCHEMBL12699907 0.85 ALDH1A1 (0.38) PTPN1ALDH1A1SMN1; SMN2HSD17B10CNR2
SCHEMBL15151455 0.83 ALDH1A1 (0.37) PTPN1ALDH1A1SMN1; SMN2HSD17B10CNR2
SCHEMBL4369317 0.83 ALDH1A1 (0.37) PTPN1ALDH1A1SMN1; SMN2HSD17B10CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118085323-A High-strength degradable polyester composite material and preparation method thereof 台州黄岩泽钰新材料科技有限公司 2024-05-28 — — CN claimed
US-11053457-B2 Cleaning composition for semiconductor substrate JSR CORPORATION (JP) 2021-07-06 — — US claimed
US-7692015-B2 Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer LIANYUNGANG JINKANG PHARMACEUTICAL TECHNOLOGY CO. LTD. (CN) 2010-04-06 — — US claimed
EP-2121680-A1 A NOVEL AND ECONOMICAL PROCESS FOR PREPARING (S,S)-2, 8-DIAZABICYCLOÝ4.3.0¨NONANE AND ITS ENANTIOMER Wang, Zheqing (US) 2009-11-25 — — EP claimed
US-20080221329-A1 Novel and economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer LIANYUNGANG JINKANG PHARMACEUTICAL TECHNOLOGY CO. LTD. (CN) 2008-09-11 — — US claimed
WO-2008085480-A1 A NOVEL AND ECONOMICAL PROCESS FOR PREPARING (S,S)-2, 8-DIAZABICYCLO[4.3.0]NONANE AND ITS ENANTIOMER WANG ZHEQING (US) 2008-07-17 — — WO claimed
US-7214834-B2 Process for preparing enantiomerically pure 1,1′-spirobiindane-6,6′-diol derivatives EASTMAN KODAK COMPANY (US) 2007-05-08 — — US claimed
EP-1768943-A1 PROCESS FOR PREPARING ENANTIOMERICALLY PURE 1,1'-SPIROBIINDANE-6,6'-DIOL DERIVATIVES EASTMAN KODAK COMPANY (US) 2007-04-04 — — EP claimed
WO-2006019663-A1 PROCESS FOR PREPARING ENANTIOMERICALLY PURE 1,1'-SPIROBIINDANE-6,6'-DIOL DERIVATIVES EASTMAN KODAK COMPANY (US) 2006-02-23 — — WO claimed
US-20060020150-A1 Process for preparing enantiomerically pure 1,1'-spirobiindane-6,6'-diol derivatives EASTMAN KODAK COMPANY 2006-01-26 — — US claimed
EP-0653065-B1 SEPARATION METHOD MARCONI OPTICAL COMPONENTS LTD (GB) 2002-10-30 — — EP claimed
EP-0660935-B1 IMMUNOLOGICAL DETECTION USING TWO DETECTABLE LABELS MARCONI GEC LTD (GB) 2000-05-24 — — EP claimed
US-5723304-A Immunological detection using two detectable labels GEC-MARCONI LIMITED (GB) 1998-03-03 — — US claimed
EP-0660935-A1 IMMUNOLOGICAL DETECTION USING TWO DETECTABLE LABELS GEC-MARCONI LIMITED (GB) 1995-07-05 — — EP claimed
EP-0653065-A1 SEPARATION METHOD GEC-MARCONI LIMITED (GB) 1995-05-17 — — EP claimed
WO-1994003807-A1 SEPARATION METHOD GEC-MARCONI LIMITED (GB) 1994-02-17 — — WO claimed
WO-1994003811-A1 IMMUNOLOGICAL DETECTION USING TWO DETECTABLE LABELS GEC-MARCONI LIMITED (GB) 1994-02-17 — — WO claimed
US-12046464-B2 Substrate cleaning composition, method for cleaning substrate using the same, and method for fabricating semiconductor device using the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-07-23 — — US disclosed
US-4303548-A Process for coating dispersed minute droplets with membrane MITSUBISHI PAPER MILLS, LTD. (JP) 1981-12-01 — — US disclosed
US-4267174-A AND PROCESS FOR ADMINISTERING BOEHRINGER MANNHEIM, GMBH (DE) 1981-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060020150-A1 Process for preparing enantiomerically pure 1,1'-spirobiindane-6,6'-diol derivatives HSD11B1, PKD1, REN PTPN1 3068/4885ALDH1A1 102/4885SMN1; SMN2 4133/4885
US-20080221329-A1 Novel and economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer SULT1E1, CYP4X1, SULT1A1 PTPN1 697/4885ALDH1A1 2646/4885SMN1; SMN2 759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.